Upstate Active Clinical Trials
Study Title:
ALTE03N1 - Key Adverse Events Following Childhood CancerWhat is the purpose of the study? (in Layman's terms, please describe the study)
Study to identify subjects who are more likely to develop late-occurring complications. Identified subjects are observed closely in order to prevent complications from occurring or to find complications early.Upstate Institutional Review Board (IRB) Number:
264681Study/Protocol ID:
ALTE03N1Study Phase:
N/APatient Age Group:
ChildrenPrincipal Investigator:
Philip MonteleoneClinicalTrials.Gov ID:
NCT00082745For more information about this trial go to ClinicalTrials.Gov
Who can I contact for more information?
Name: Karen B Bilynsky
Phone: 315-464-7601
Email: bilynskk@upstate.edu